Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-115P (RNA, U1 small nuclear 115, pseudogene) is a predicted pseudogene related to the family of U1 small nuclear RNAs (snRNAs). Unlike canonical U1 snRNA genes, pseudogenes such as RNU1-115P do not typically encode functional RNA products, as they arise from gene duplication or retrotransposition events but acquire mutations that prevent their normal biological activity[3]. U1 snRNAs are critical components of the spliceosome complex, mediating pre-mRNA splicing and other aspects of RNA metabolism[1][2]. However, pseudogene copies (including RNU1-115P) exhibit sequence similarity to functional U1 snRNAs but are generally transcriptionally silent or produce non-functional transcripts that do not participate in spliceosome assembly or function[3]. There is no evidence supporting a direct role for RNU1-115P in human disease, therapeutic targeting, or use as a biomarker. Pseudogenes like RNU1-115P are most often used as genomic markers for evolutionary or bioinformatic studies rather than functional biological targets[3]. Key clarifications: - RNU1-115P is a pseudogene, not a canonical functional snRNA or therapeutic target. - There are many U1 small nuclear RNA pseudogenes within the human genome, mapping to regions distinct from the functional U1 genes[3]. - No drugs or diseases are associated with RNU1-115P, nor does it possess mechanisms of action or safety concerns relevant to therapy. If structured information is required for a functional U1 snRNA gene (such as RNU1-1), that would yield very different classifications, biological functions, and potential disease relevance[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 115, pseudogene (RNU1-115P).